Orthopaedic Oncology (Subscribe)
Categories
- Bone Metastases (29)
- Management of metstatic cancer deposits in bone
- Connective and Soft Tissue Neoplasms (507)
- Neoplasms developing from some structure of the connective and subcutaneous tissue. OCOSH Code C04.557.450_BD_BN_CTS
- Lymphoma (21)
- A general term for various neoplastic diseases of the lymphoid tissue. OCOSH Code C04.557.386_BD_BN_L
Links
Adult Cancer Information Summaries PDQ
Physician Data Query (PDQ) Cancer Information summaries
Alphabetical List of PDQ® Adult Cancer Treatment Summaries
Alphabetical List of PDQ® Adult Cancer Treatment Summaries
Atlas Solid Tumors
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Editor: Jean-Loup Huret, Genetics DIM, University Hospital, F-86021 Poitiers, France
Benign and Malignant Soft Tissue Tumors eMedicine
Present achievements in the field of soft tissue tumors are the result of advances in molecular biology, oncogenetics, imaging techniques, immunochemistry, diagnosis by fine-needle aspiration, surgical reconstruction, radiation therapy, and tissue banking. Benign soft tissue tumors are fairly common and are treated with surgery alone. Prior to the 1970s, surgery was the primary therapy for malignant soft tissue tumors, and most patients with high-grade tumors had a poor prognosis and a significant mortality rate. Since the mid-1970s, radiation therapy, chemotherapy, and advanced surgical techniques have helped increase long-term survival and decrease the need for ablative surgery. Future advances in molecular oncology may further improve diagnostic, prognostic, and treatment protocols for patients with soft tissue sarcomas.
Better Bone Health
f you are experiencing bone pain from multiple myeloma, or want to know about bone metastases that can occur in almost any cancer including breast cancer, lung cancer, prostate cancer, thyroid cancer, kidney cancer, and colon cancer, visit BetterBoneHealth.com.
Clinical Trials
Database of clinical trials maintained by US National Institute of Health
Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL
J Orthop Surg (Hong Kong). 2001 Dec;9(2):19-22 Clayer M, Bouralexis S, Evdokiou A, Hay S, Atkins GJ, Findlay DM.
The Queen Elizabeth Hospital, Adelaide, Australia.
Soft tissue sarcomas are less responsive to conventional chemotherapy when compared to bone sarcomas. We investigated the possibility of enhancing the efficacy of chemotherapy by utilising the recently identified cytokine, tumour necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) in combination with standard chemotherapeutic agents. Fresh human soft tissue sarcomas (rhabdomyosarcoma, fibrosarcoma, malignant fibrous histiocytoma) were obtained at biopsy and dispersed tumour cells were incubated in cell culture with standard cytotoxic agents, either as single agents or in combination with TRAIL. The chemotherapeutic agents were, at best, moderately effective, in terms of induction of cellular apoptosis, although the fibrosarcoma was completely unresponsive to all single agents. TRAIL alone had no effect on any sarcoma cell culture. In contrast, the addition of TRAIL and drug together produced a significant increase in sarcoma cell apoptosis, with TRAIL and doxorubicin the most effective combination.
Soft tissue sarcomas are less responsive to conventional chemotherapy when compared to bone sarcomas. We investigated the possibility of enhancing the efficacy of chemotherapy by utilising the recently identified cytokine, tumour necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) in combination with standard chemotherapeutic agents. Fresh human soft tissue sarcomas (rhabdomyosarcoma, fibrosarcoma, malignant fibrous histiocytoma) were obtained at biopsy and dispersed tumour cells were incubated in cell culture with standard cytotoxic agents, either as single agents or in combination with TRAIL. The chemotherapeutic agents were, at best, moderately effective, in terms of induction of cellular apoptosis, although the fibrosarcoma was completely unresponsive to all single agents. TRAIL alone had no effect on any sarcoma cell culture. In contrast, the addition of TRAIL and drug together produced a significant increase in sarcoma cell apoptosis, with TRAIL and doxorubicin the most effective combination.
Key Statistics about Bone Cancer
Patient Oriented. Links to pages on causes, early detection and treatment
Key Statistics about Soft Tissue Sarcoma
Patient oriented. Links to causes, detection and treatment
Limb Salvage
Definition
Limb salvage surgery is a type of surgery primarily performed to remove bone and soft-tissue cancers occurring in limbs in order to avoid amputation.
Encyclopedia of Surgery: A Guide for Patients and Caregivers
Malignant Hand Tumors eMedicine
Although tumors of the hand are rather common, most are benign and only 1-2% are malignant. When evaluating a hand lesion, be judicious and maintain a high index of suspicion for malignancy. Malignant hand tumors are complex and challenging entities for the hand surgeon.
Beckert & Concannon
Beckert & Concannon
Oncology Global-HELP
Drs. J.J. Cuevas Torres & J.A. Santos Miranda, along with over 40 medical professionals, compile in their native Spanish an extensive and well-illustrated book on basic Oncology.
Orthopaedic Pathology Orthoteers
Major teaching resource on orthopaedic pathology. Requires registration for access to full text.
Radiographic Imaging of Musculoskeletal Neoplasia
Background: Imaging is an integral part of the diagnosis, staging and evaluation of outcomes for bone and soft-tissue neoplasms. Each of the available imaging tools has a different role.
Methods: The authors reviewed the efficacy of the current imaging modalities in the diagnosis, staging, and follow-up of patients with musculoskeletal neoplasia.
Results: Plain-film radiography remains the gold standard in the differential diagnosis of bone lesions. Bone scintigraphy is an excellent screening modality, and computed tomography is especially useful in evaluating lesions of the axial skeleton. The superior soft-tissue resolution and multiplanar capabilities achieved with magnetic resonance imaging, however, has replaced the need for CT scans in many cases.
Conclusions: The technological advances seen in recent years in all areas of imaging have improved the capabilities of these modalities to assist in the diagnosis, definition of tumor extent, and accurate staging of musculoskeletal tumors.
from Cancer Control: Journal of the Moffitt Cancer Center
Timothy G. Sanders, MD, and Theodore W. Parsons III, MD, FACS, Departments of Radiology (TGS) and Orthopaedics (TWP) at the Wilford Hall Medical Center and the University of Texas at San Antonio. (Full text)
from Cancer Control: Journal of the Moffitt Cancer Center
Timothy G. Sanders, MD, and Theodore W. Parsons III, MD, FACS, Departments of Radiology (TGS) and Orthopaedics (TWP) at the Wilford Hall Medical Center and the University of Texas at San Antonio. (Full text)
Rare Bone Tumours
Illustrated cases from the experience of Dr Vinod Naneria, Indore, MP, India
Cases include synovial chondromatosis, fibromatosis, haemangiomas, Osteochondritis dissecans, Multiple Myeloma, Osteoid Osteoma, Osteochondroma, Lipoma, Fibroma, Non-ossifying Fibroma, Fibrous cortical defects, Paget Disease, Osteogenesis Imperfecta, Osteopetrosis, Hyperparathyroidism, Neurofibromatosis, Neurilemoma
Cases include synovial chondromatosis, fibromatosis, haemangiomas, Osteochondritis dissecans, Multiple Myeloma, Osteoid Osteoma, Osteochondroma, Lipoma, Fibroma, Non-ossifying Fibroma, Fibrous cortical defects, Paget Disease, Osteogenesis Imperfecta, Osteopetrosis, Hyperparathyroidism, Neurofibromatosis, Neurilemoma

